Dr. Olayinka Olaniyan

Dr. Yinka Olaniyan, is an Obstetrician and Gynaecologist. He is currently MD/CEO of Green Acres Hospital & Gynaecare Clinic in Abuja. He is also visiting consultant to National Hospital Abuja.

Dr. Olaniyan, received his basic medical degree (MBBS) from the University of Lagos in 1983 and obtained the post graduate fellowship of the West African College of Surgeons (FWACS Obstetrics & Gynaecology) in 1998. He also holds a Post-Graduate Diploma in Reproductive Medicine and Biology from the University of Geneva (2000). He undertook a Basic Colposcopy Training at the Geneva University Hospital. He is passionate about cancer prevention in belief that prevention holds the key to eradication of cancer especially in developing countries. His research interests focus on identifying the determinants in the aetiology of cervical cancer and development of its screening modalities.

He served as consultant to CADRE – Capacity Development for Research into AIDS Associated malignancies, a collaboration of Institute of Human Virology Nigeria (IHVN) and the University of Baltimore, which investigated, screened and treated HIV infected women for cervical cancer. He is also part of the African Collaborative Centre for Microbiome & Genomics Research (ACCME), an arm of the Human Heredity and Health in Africa (H3Africa) consortium, which aims to facilitate a contemporary research approach to the study of genomics and environmental determinants of common diseases with the goal of improving the health of African populations. Dr. Olaniyan holds a Diploma of the National Cancer Institute USA and is also a fellow of the Union of International Cancer Control (UICC). He has received an award from American Society for Clinical Oncology (ASCO) for his contribution to cancer education and his leadership role in the African Organisation for Research and Training in Cancer(AORTIC).

Dr. Olaniyan retired from public service in 2017 and now runs a private gynaecology practice in Abuja where his services include a modern colposcopy and treatment of cervical pre-cancer service, receiving referrals from across Nigeria.

 

Positions and Honors.

Positions:

  • 2017 – present     Visiting Consultant, Obstetrics & Gynaecology, National Hospital Abuja 
  • 2014-2015             Head of Obstetrics & Gynaecology, National Hospital, Abuja
  • 2011                       Visiting Fellow, Clinical Trials, Montefiore Medical Centre, Albert Einstein University, New York USA
  • 2010                       Surgical Oncology Fellow, Regional Cancer Centre, Trivandrum, Kerala State, India
  • 2008                       BSCCP Overseas Scholarship – RCOG Intermediate/Advanced Colposcopy Course #British Society for Colposcopy & Cervical Pathology, Royal College of Obstetrics & Gynaecology
  • 2003                       Post-Doctoral Fellow, National Cancer Institute Curriculum in Cancer Prevention and Epidemiology, Bethesda, Maryland USA.
  • 2003                       Visiting Fellow Georgia Center for Cancer Statistics, SEER Registry, School of Public Health, Emory University, Atlanta Georgia, USA
  • 2002                       Cancer Registry Training Fellowship, Kenya Medical Research Institute, Nairobi Kenya 
  • 2000                       Post-Doctoral Fellow/Colposcopy Training, Gynae-oncology Unit. Groote-Schuur Hospital, University of Cape Town, Republic of South Africa

 

Honors

  • Fellow of the Union for International Cancer Control
  • Diploma of the National Cancer Institute USA
  • American Society for Clinical Oncology (ASCO) award

 

Selected Other Professional Activities

  • 2017 – date         MD/CEO Green Acres Hospital & Gynaecare Clinic
  • 2006 –2015        Consultant: Nigerian National Petroleum Corporation (NNPC) Cancer Screening Clinic.
  • 2010-2012           Project Consultant: Adamawa State Early Cancer Detection Program
  • 2007                     Course Coordinator: ASCO/AORTIC* International Multidisciplinary Course in Cancer Management. Jan 2007, Abuja. *American Society of Clinical Oncology/African Organization for Research & Training in Cancer
  • 2008                     Course Coordinator: UICC**/National Hospital Colposcopy Training Course.    Sept 23-25 2008. **Union for International Cancer Control
  • 2009 –                   Consultant: Nigerian Air-Force Officers’ Wives Association (NAFOWA) Cancer Screening Centre.
  • 2010 – 2017        Project Consultant: Institute of Human Virology (IHVN) Cervical Cancer Screening project.
  • 2010 – 2017        Regional Coordinator FMOH*** Cervical Cancer Screening Program, North Central Zone                                   ***Federal Ministry of Health

Dr. Olaniyan is a keen photographer, Jazz saxophonist and a grandfather.

PUBLICATION LIST

  1. Genome-wide association study of prevalent and persistent cervical high-risk human papillomavirus (HPV) infection. Sally N. Adebamowo 1,2*, Adebowale A. Adeyemo3, Charles N. Rotimi3, Olayinka Olaniyan4, Richard Offiong5,Clement A. Adebamowo 1,2,6,7and for the H3Africa ACCME Research Group. BMC Medical Genetics (2020) 21:231 https://doi.org/10.1186/s12881-020-01156-1
  2. Clearance of Type-Specific, Low-Risk, and High-Risk Cervical Human Papillomavirus Infections in HIV-Negative and HIV-Positive Women. Adebamowo SN, Famooto A, Dareng EO, Olawande O, Olaniyan O, Offiong R, Adebamowo CA. J Glob Oncol. 2018 Jul;4:1-12. doi: 10.1200/JGO.17.00129. PMID: 30125130 
  3. Cohort Profile: African Collaborative Center for Microbiome and Genomics Research’s (ACCME’s) Human Papillomavirus (HPV) and Cervical Cancer Study. Adebamowo SN, Dareng EO, Famooto AO, Offiong R, Olaniyan O, Obende K, Adebayo A, Ologun S, Alabi B, Achara P, Bakare RA, Odutola M, Olawande O, Okuma J, Odonye G, Adebiyi R, Dakum P, Adebamowo CA; ACCME Research Group as part of the H3Africa Consortium. Int J Epidemiol. 2017 Dec 1;46(6):1745-1745j. doi: 10.1093/ije/dyx050. PMID: 28419249
  4. Integrated genomic and molecular characterization of cervical cancer. Cancer Genome Atlas Research Network; Albert Einstein College of Medicine; Analytical Biological Services; Barretos Cancer Hospital; Baylor College of Medicine; Beckman Research Institute of City of Hope; Buck Institute for Research on Aging; Canada’s Michael Smith Genome Sciences Centre; Harvard Medical School; Helen F. Graham Cancer Center &Research Institute at Christiana Care Health Services; HudsonAlpha Institute for Biotechnology; ILSbio, LLC; Indiana University School of Medicine; Institute of Human Virology; Institute for Systems Biology; International Genomics Consortium; Leidos Biomedical; Massachusetts General Hospital; McDonnell Genome Institute at Washington University; Medical College of Wisconsin; Medical University of South Carolina; Memorial Sloan Kettering Cancer Center; Montefiore Medical Center; NantOmics; National Cancer Institute; National Hospital, Abuja, Nigeria; National Human Genome Research Institute; National Institute of Environmental Health Sciences; National Institute on Deafness &Other Communication Disorders; Ontario Tumour Bank, London Health Sciences Centre; Ontario Tumour Bank, Ontario Institute for Cancer Research; Ontario Tumour Bank, The Ottawa Hospital; Oregon Health &Science University; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center; SRA International; St Joseph’s Candler Health System; Eli &Edythe L. Broad Institute of Massachusetts Institute of Technology &Harvard University; Research Institute at Nationwide Children’s Hospital; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University; University of Bergen; University of Texas MD Anderson Cancer Center; University of Abuja Teaching Hospital; University of Alabama at Birmingham; University of California, Irvine; University of California Santa Cruz; University of Kansas Medical Center; University of Lausanne; University of New Mexico Health Sciences Center; University of North Carolina at Chapel Hill; University of Oklahoma Health Sciences Center; University of Pittsburgh; University of São Paulo, Ribeir ão Preto Medical School; University of Southern California; University of Washington; University of Wisconsin School of Medicine &Public Health; Van Andel Research Institute; Washington University in St Louis. Nature. 2017 Mar 16;543(7645):378-384. doi: 10.1038/nature21386. Epub 2017 Jan 23. PMID: 28112728
  5. Cohort Profile: African Collaborative Center for Microbiome and Genomics Research (ACCME) Human Papillomavirus (HPV) and Cervical Cancer Study. Sally N. Adebamowo,1,2,3* Eileen O. Dareng,4 Ayotunde O. Famooto,5 Richard Offiong,6 Olayinka Olaniyan,7 Kayode Obende,8 Amos Adebayo,9 Sanni Ologun,10 Bunmi Alabi,11 Peter Achara,12 Rasheed A. Bakare,13 Michael Odutola,5Oluwatoyosi Olawande,5 James Okuma,5 George Odonye,5 Ruxton Adebiyi,5 Patrick Dakum14 and Clement A. Adebamowo, 1,2,3,5,15; ACCME Research Group as part of the H3Africa Consortium. International Journal of Epidemiology, 2017, 1–11 doi: 10.1093/ije/dyx050 Cohort Profile
  6. Recurrence of cervical intraepithelial lesions after thermo-coagulation in HIV-positive and HIV-negative Nigerian women. Oga EA, Brown JP, Brown C, Dareng E, Adekanmbi V, Odutola M, Olaniyan O, Offiong R, Obende K, Adewole AS, Peter A, Dakum P, Adebamowo C. BMC Womens Health. 2016 May 11;16:25. doi: 10.1186/s12905-016-0304-8. PMID: 27169666 Free PMC Article
  7. Qualitative study of barriers to cervical cancer screening among Nigerian women. Isa Modibbo F, Dareng E, Bamisaye P, Jedy-Agba E, Adewole A, Oyeneyin L, Olaniyan O, Adebamowo C. BMJ Open. 2016 Jan 11;6(1):e008533. doi: 10.1136/bmjopen-2015-008533. PMID:
  8. Influence of Spirituality and Modesty on Acceptance of Self-Sampling for Cervical Cancer. Dareng EO, Jedy-Agba E, Bamisaye P, Isa Modibbo F, Oyeneyin LO, Adewole AS, Olaniyan OB, Dakum PS, Pharoah PD, Adebamowo CA. PLoS One. 2015 Nov 3;10(11):e0141679. doi: 10.1371/journal.pone.0141679. eCollection 2015. PMID: 26529098 Free PMC Article
  9. Age-specific prevalence of human papilloma virus infection among Nigerian women. Akarolo-Anthony SN, Famooto AO, Dareng EO, Olaniyan OB, Offiong R, Wheeler CM, Adebamowo CA. BMC Public Health. 2014 Jun 27;14:656. doi: 10.1186/1471-2458-14-656. PMID: 24972674
  10. HIV associated high-risk HPV infection among Nigerian women. Akarolo-Anthony SN, Al-Mujtaba M, Famooto AO, Dareng EO, Olaniyan OB, Offiong R, Wheeler CM, Adebamowo CA. BMC Infect Dis. 2013 Nov 5;13:521. doi: 10.1186/1471-2334-13-521. PMID: 24192311
  11. RPS19 and TYMS SNPs and Prevalent High Risk Human Papilloma Virus Infection in Nigerian Women. Famooto A, Almujtaba M, Dareng E, Akarolo-Anthony S, Ogbonna C, Offiong R, Olaniyan O, Wheeler CM, Doumatey A, Rotimi CN, Adeyemo A, Adebamowo CA. PLoS One. 2013 Jun 27;8(6):e66930. doi: 10.1371/journal.pone.0066930. Print 2013. PMID: 23826176
  12. Cervical cancer risk factors among HIV-infected Nigerian women. Ononogbu U, Almujtaba M, Modibbo F, Lawal I, Offiong R, Olaniyan O, Dakum P, Spiegelman D, Blattner W, Adebamowo C. BMC Public Health. 2013 Jun 14;13:582. doi: 10.1186/1471-2458-13-582. PMID: 23767681
  13. Negative Urine HCG in Choriocarcinoma. Olaniyan OB, Momoh JAF. Int J Gynecol Obstet. 2007;98(1);59-60
  14. Abnormal Cytology in Human Immunodeficiency Virus Positive Women Referred for Colposcopy: An Analysis of Cytologic-Colposcopic-Histologic Correlation. Olaniyan OB., Denny L. Trop J Obstet Gynaecol 2005;22(2):129-132.
  15. Validity of colposcopy in the diagnosis of early cervical neoplasia–a review. Olaniyan OB. Afr J Reprod Health. 2002 Dec;6(3):59-69. PMID: 12685410
  16. Knowledge and Practice of Cervical Screening Among Female Health Workers in Government Hospitals in Abuja Metropolis. Olaniyan OB, Agboghoroma OC, Ladipo OP. Trop J Obstet Gynaecol,2000,17:18-20.
  17. Utilization of Cervical Cytology in Abuja. Olaniyan OB, Mukhtar Au, Offiong R, Ladipo OP. Nig. Qt .J.  Hosp. Med. 2000 Vol. 10 (3). 178-180.